Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance. - Wikidata - wikimedia - TriplyDB

Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance.

Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance.

http://www.wikidata.org/entity/Q39197858

about

The Role of Autophagy in Hepatocellular Carcinoma Predicting Response to Histone Deacetylase Inhibitors Using High-Throughput Genomics.Knockdown of autophagy-related protein 5, ATG5, decreases oxidative stress and has an opposing effect on camptothecin-induced cytotoxicity in osteosarcoma cells Targeting Histone Deacetylases in Diseases: Where Are We?Co-delivery of Gefitinib and chloroquine by chitosan nanoparticles for overcoming the drug acquired resistance.Broad targeting of resistance to apoptosis in cancer.Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer.Autophagy: A novel therapeutic target for hepatocarcinoma (Review).Autophagy and cancer metabolism.Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects.How do tumor cells respond to HDAC inhibition?Therapeutic Implications of Autophagy Inducers in Immunological Disorders, Infection, and Cancer.Peroxisomes protect lymphoma cells from HDAC inhibitor-mediated apoptosis.Astragaloside II sensitizes human hepatocellular carcinoma cells to 5-fluorouracil via suppression of autophagy.Increased protein processing gene signature in HDACi-resistant cells predicts response to proteasome inhibitors.

P2860

Q26777419-32B928E8-56A6-4A39-941B-BA3398BB5B50 Q33425333-E2DD5F56-73F9-4C12-86E8-984355653F78 Q35026243-9D7943E8-91CC-487D-9893-83614FC7E750 Q35821728-90F1101B-E739-48A7-8489-6FF91AC21229 Q36085847-A554A1F9-440C-4371-B04E-531D2974231A Q36483749-2643E1DC-82CC-41D1-B1DB-5E6ABF2C6860 Q37536938-95B6BE85-881D-4F93-A4EE-06F4A7BCD5B8 Q37720015-C65A4EE9-4C13-4324-9769-5E1335338BF6 Q38214981-9AC20441-6EB3-4DD9-A3CA-EA9B5335516D Q38240733-08E0C0A5-06F9-49A2-A484-B9D6F9809176 Q38689955-5B7BE71C-25A8-44A5-8886-B7A13D225E2C Q38817005-B29F4398-FC6C-4098-AFC9-D071563E53BF Q40051484-BAB5CDAC-504B-43BF-B533-0AAF1C655457 Q42706138-1F50048B-9D75-4245-8C51-F0DA3C956FC6 Q51108783-CBC85CD1-8BEC-4E41-BE97-D3F02E8E6045 Q52869149-3F0EF367-F974-433E-834A-75661F3FCCA1

P2860

Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance.

http://www.wikidata.org/entity/Q39197858

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Vorinostat-induced autophagy s ...... to drive acquired resistance.

@en

Vorinostat-induced autophagy s ...... to drive acquired resistance.

@nl

type

label

Vorinostat-induced autophagy s ...... to drive acquired resistance.

@en

Vorinostat-induced autophagy s ...... to drive acquired resistance.

@nl

prefLabel

Vorinostat-induced autophagy s ...... to drive acquired resistance.

@en

Vorinostat-induced autophagy s ...... to drive acquired resistance.

@nl

P1433

Q39197858-7705D4A1-04B7-403C-A5A0-736758F83CCF

P1476

Q39197858-E11DF1D7-2871-49F4-BDE5-92A6187252B4

P2093

Q39197858-3E0FAA43-43AC-4F9F-8413-6A9E6643FFEC

Q39197858-51861D04-991C-4A9B-BC1D-428E8454710D

Q39197858-5195AAFB-1303-4FF0-81CA-9F23C94710EC

Q39197858-5BDC2921-99AA-4A51-8BF8-37865F7B9E8E

Q39197858-5D600C12-B515-4359-A8A3-6544DE27F2F1

Q39197858-9A50FE12-B214-476A-8EB3-992194EBF118

Q39197858-A9F40276-FFB3-47E7-BDEB-13A427D8E406

P2860

Q39197858-0CDFCF51-5087-4B3A-BCCC-5CA870144984

Q39197858-167DD444-5E0A-4AB1-A2F3-1EBED5E30A3E

Q39197858-2428E255-4F6A-4115-823E-584069ADD4B8

Q39197858-25C18155-0F60-4476-A6D5-98C806EFA484

Q39197858-26998093-366E-4AA8-A05D-29DB15ADE012

Q39197858-27FE94C0-2C19-4B30-893E-C671F6B3BA08

Q39197858-2DCA051E-CFC2-43DD-9AA2-9F85E8481DAD

Q39197858-2E4BD767-EE08-4AAD-B1CB-CBA1237E1299

Q39197858-2EC96582-9B42-45AA-BF6C-1B571E24108E

Q39197858-32062DD2-5BA0-4F4C-9F3F-B5700F2A44DF

P304

Q39197858-FDB266F2-BF15-4F51-A65B-AC6816778237

P31

Q39197858-160D8755-1B01-439E-AC55-AC4F2F4CBC4A

P356

Q39197858-EF0BD704-EF89-4B4D-97CD-25387A096A9C

P478

Q39197858-65BF92CC-FF42-49EB-83D0-D3B5A774A50E

P577

Q39197858-C7637B64-E9D5-48D7-A8A8-8D68E0459B46

P5875

Q39197858-3E2F1A67-D54F-486D-B3A8-5AB435885B97

P698

Q39197858-9CB69D8E-6976-4C62-AC32-DB78856D26EA

P921

Q39197858-E70A37CD-9B71-4F83-A092-7232FDB4E97F

P932

Q39197858-B7BAB2C9-BD77-46B7-990D-65C1CB9DBEA9

P356

P1433

Cell Death and Disease

P1476

Vorinostat-induced autophagy s ...... to drive acquired resistance.

@en

P2093

D Dupéré-Richer

http://www.w3.org/2001/XMLSchema#string

F Pettersson

http://www.w3.org/2001/XMLSchema#string

M Kinal

http://www.w3.org/2001/XMLSchema#string

S Del Rincon

http://www.w3.org/2001/XMLSchema#string

T H Nielsen

http://www.w3.org/2001/XMLSchema#string

V Ménasché

http://www.w3.org/2001/XMLSchema#string

W H Miller

http://www.w3.org/2001/XMLSchema#string

P2860

Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks

Lysine acetylation targets protein complexes and co-regulates major cellular functions

The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53

Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound β-phenylethyl isothiocyanate

Growth factor regulation of autophagy and cell survival in the absence of apoptosis

Vorinostat induces reactive oxygen species and DNA damage in acute myeloid leukemia cells

Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes

Targeting the phosphoinositide 3-kinase pathway in cancer

Potential therapeutic applications of autophagy

P304

e486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CDDIS.2012.210

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235422171

http://www.w3.org/2001/XMLSchema#string

P698

23392174

http://www.w3.org/2001/XMLSchema#string

P921

P932

3734816

http://www.w3.org/2001/XMLSchema#string